Kristy Galante is a Senior Director at Janssen R&D focusing on Rare Disease in Immunology. Kristy has over 20 years of clinical trial experience where she has focused on both prevalent disease and now primarily on rare disease. Kristy is seen as an expert in supporting complex clinical trial operations and advocates for the site and patient voice in trial development. With a strong passion for innovation, Kristy has been able to support new clinical trial solutions with successful launch across the Immunology portfolio. Kristy has also had leadership roles in Janssen Strategic Partnerships focusing on CRO Governance, Process and Performance Metrics. Kristy supported the Johnson and Johnson COVID vaccine program ensuring supplier alignment and deploying many novel innovative tactics. Kristy has her MS from Temple University School of Pharmacy.
